Abatacept as effective as adalimumab in rheumatoid arthritis
(European League Against Rheumatism) Data from AMPLE presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate comparable efficacy and similar safety profiles between subcutaneous abatacept and adalimumab.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Abatacept | Arthritis | Health | Humira | International Medicine & Public Health | Orencia | Politics | Rheumatoid Arthritis | Rheumatology